Ceprotin Kit
Product Images NDC 0944-4179

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Ceprotin (NDC 0944-4179). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ceprotin 01

FDA Label Image

Ceprotin 02

FDA Label Image

Ceprotin 03

FDA Label Image

Ceprotin 04

FDA Label Image

Ceprotin 05

CEPROTIN is a human protein C concentrate, a product of Austria, which comes in a single-use vial containing approximately 100 1U/mL. The vial includes Sterile Water for Injection, USP produced in Germany, a double-ended transfer needle, a filter needle, a full prescribing physician insert and a patient package insert. It is used for intravenous administration only, and must be stored at a temperature between 2-8°C to prevent damage to the diluent bottle. The protein C concentrate contains human albumin, rsodium drate diycrate, and sodium chloride as excipients. The manufacturer Baxalta US, Inc. is located in Lexington, MA, and CEPROTIN is a registered trademark of Baxalta Incorporated, a wholly-owned indirect subsidiary of Shire pic. The Shire logo is a registered trademark of Shire Pharmaceutical Holdings Ireland Limited or affiliates. NDC 0044-4177-05.*

FDA Label Image

Ceprotin 06

This is a description of a protein C concentrate that comes in a single-dose vial and is meant for intravenous administration only. The product, EPROTIN, is a lyophilized powder that must be mixed with a solution for injection. The packaging recommends reviewing the package insert and notes that this is a prescription-only medication. The manufacturer is Axalta US Inc. located in Lexington, MA with license number 2020. There is a lot number and expiration date listed but they are not readable in the output.*

FDA Label Image

Ceprotin 07

This is a description of a pharmaceutical product. The product is a sterile water for injection in a 5 mL single-dose container. It has an NDC number of 52919-003-08 and is manufactured by Shire S. The water is intended to be used for reconstitution of an accompanying product, but should not be used for intravascular injection without being made isotonic by adding a suitable solute. It does not contain any antimicrobial agents or other substances. The unused portion should be discarded and the product is only available on prescription (Rx only). The label also indicates the lot number and expiration date, and that the container is nonpyrogenic.*

FDA Label Image

Ceprotin 08

This is a product information sheet for CEPROTIN, a lyophilized powder for intravenous administration that contains Protein G Concentrate (Human). It is to be reconstituted with sterile water and should be administered within 3 hours of reconstitution. The product should be stored refrigerated and protected from freezing. The sheet includes a list of trademarks of Baxalta and Shire, the manufacturers of CEPROTIN, as well as the list of contents for a single CEPROTIN vial that includes human protein C, human albumin, trisodium citrate dihydrate, and sodium chloride.*

FDA Label Image

Ceprotin 09

CEPROTIN is a single-dose vial containing lyophilized powder for intravenous injection. It is a protein C concentrate derived from human sources. The product should only be administered intravenously and for this reason, the package insert should be consulted. RX only. The expiration date is not available.*

FDA Label Image

Ceprotin 10

This is a description of a pharmaceutical product with the National Drug Code 52919-005-05. It includes a 10 mL container of sterile water intended for injection and for use in the reconstitution of another product. It is important not to use it unless the solution is clear, and to make it isotonic before intravascular injection. The product is single-dose and non-pyrogenic. There is also information on the lot number and expiration date provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.